HCW Biologics Inc. (HCWB): Total Assets
$24.52M
As of 2025-12-31
$26.77M
As of 2026-06-30
-19.4%
3-year compound annual growth
+9.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.52M | -18.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $30.24M | +6.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $28.51M | -39.1% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $46.81M | -12.5% | 2024-05-15, Balance as of period end |
| 2021-12-31 | $53.51M | +247.5% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $15.40M | n/a | 2022-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $9.94M | +20.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
Compare HCWB, LNAI, AVTX, CNTB side by side · Screen every company in Pharmaceutical Preparations ↗